{"disease":{"id":"mtap-deleted-solid-tumors","name":"mtap deleted solid tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06914128","title":"A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":370,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06188702","title":"S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":342,"lead_sponsor_name":"Servier Bio-Innovation LLC","has_results":false},{"nct_id":"NCT06568614","title":"An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":29,"lead_sponsor_name":"BeOne Medicines","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}